Fund shareholders of Denali Therapeutics Inc
ISIN US24823R1059 · United States · LEI 549300ZTQ2HO18L3Q830
- Fund shareholders
- 257
- Of which ETFs
- 51 206 other funds
- Value held
- 1B $ 77.3K € · 8M SEK
- Share of capital
- 32.8 % of 159.8M shares on Jul 31, 2026
257 funds hold this company. This table lists the 256 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Tax-Aware Overlay A Portfolio BERNSTEIN SANFORD C FUND INC | 4,135 | 79.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PRAXIS SMALL CAP INDEX FUND Praxis Mutual Funds | 4,027 | 77.3K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional US Vector Equity ETF Dimensional ETF Trust | 4,027 | 75.4K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SA T. Rowe Price Allocation Moderately Aggressive Portfolio SUNAMERICA SERIES TRUST | 3,734 | 69.9K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 3,727 | 71.6K $ | 0.09 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 3,531 | 67.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT AGGRESSIVE ALLOCATION FUND Thrivent Mutual Funds | 3,463 | 64.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 3,383 | 65K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Moderate Allocation Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 3,358 | 64.5K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 3,311 | 70.1K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 3,237 | 62.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA Goldman Sachs Multi-Asset Insights Portfolio SUNAMERICA SERIES TRUST | 3,024 | 56.6K $ | 0.10 % | 0.00 % | as of Apr 30, 2026 ↗ |
| THRIVENT AGGRESSIVE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. | 2,925 | 56.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 2,697 | 51.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA Multi-Managed Small Cap Portfolio SEASONS SERIES TRUST | 2,644 | 50.8K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| New Covenant Growth Fund NEW COVENANT FUNDS | 2,631 | 50.5K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 2,540 | 47.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 2,390 | 45.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT MODERATE ALLOCATION FUND Thrivent Mutual Funds | 2,231 | 41.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| THRIVENT GLOBAL STOCK FUND Thrivent Mutual Funds | 2,007 | 37.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| THRIVENT MODERATELY CONSERVATIVE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. | 1,895 | 36.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 1,799 | 34.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Overlay A Portfolio BERNSTEIN SANFORD C FUND INC | 1,699 | 32.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT GLOBAL STOCK PORTFOLIO Thrivent Series Fund, Inc. | 1,661 | 31.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 1,606 | 30.1K $ | 0.05 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust | 1,467 | 28.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Invesco Russell 2000 Dynamic Multifactor ETF Invesco Exchange-Traded Self-Indexed Fund Trust | 1,423 | 30.1K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Multimanager Aggressive Equity Portfolio EQ Advisors Trust | 1,300 | 25K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIIT MULTI-ASSET REAL RETURN FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 1,280 | 27.1K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 1,241 | 23.2K $ | 0.15 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Morgan Stanley Small Cap Growth Portfolio EQ Advisors Trust | 991 | 19K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIMT Multi-Asset Inflation Managed Fund SEI INSTITUTIONAL MANAGED TRUST | 876 | 16.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Equity Fund American Century ETF Trust | 843 | 17.9K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis Responsible U.S. Equity ETF American Century ETF Trust | 828 | 17.5K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 750 | 14.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 733 | 13.7K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 698 | 13.4K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 627 | 12K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PD Small-Cap Growth Index Portfolio PACIFIC SELECT FUND | 608 | 11.7K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 523 | 9.8K $ | 0.13 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 476 | 9.1K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 383 | 7.2K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 360 | 6.9K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 321 | 6.2K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT MODERATELY CONSERVATIVE ALLOCATION FUND Thrivent Mutual Funds | 319 | 6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Small Company Value Portfolio Wilshire Mutual Funds Inc | 300 | 5.8K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 260 | 4.9K $ | 0.06 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 192 | 3.7K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 136 | 2.9K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 131 | 2.5K $ | 0.08 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 85 | 1.8K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 40 | 847.2 $ | 0.08 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 37 | 710.4 $ | 0.00 % | as of Mar 31, 2026 ↗ | |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 35 | 672 $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Inflation Focused Equity ETF American Century ETF Trust | 12 | 254.2 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| TOP CLASS HEALTHCARE, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 77.3K € | 0.58 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| iShares Neuroscience and Healthcare ETF iShares Trust | 2.82 % | as of Apr 30, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 2.01 % | as of Feb 28, 2026 ↗ |
| DANA EPIPHANY SMALL CAP EQUITY FUND Valued Advisers Trust | 0.99 % | as of Apr 30, 2026 ↗ |
| SBH SMALL CAP GROWTH FUND Segall Bryant & Hamill Trust | 0.95 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.77 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.73 % | as of Mar 31, 2026 ↗ |
| Baillie Gifford U.S. Equity Growth Fund Baillie Gifford Funds | 0.73 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 0.71 % | as of Mar 31, 2026 ↗ |
| Edmond de Rothschild Fund - Healthcare Edmond de Rothschild Asset Management (Luxembourg) | 0.65 % | as of Mar 31, 2025 ↗ |
| SmallCap Account Principal Variable Contract Funds, Inc | 0.59 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 254 | +12 | 52,319,900 | +0.6 % |
| 2026Q1 | 242 | -4 | 52,007,607 | +1.5 % |
| 2025Q4 | 246 | -7 | 51,254,852 | -6.2 % |
| 2025Q3 | 253 | -10 | 54,647,730 | -8.2 % |
| 2025Q2 | 263 | -4 | 59,537,460 | +2.6 % |
| 2025Q1 | 267 | -7 | 58,003,123 | -3.3 % |
| 2024Q4 | 274 | +28 | 59,965,071 | +13.0 % |
| 2024Q3 | 246 | +4 | 53,058,998 | +6.1 % |
| 2024Q2 | 242 | +11 | 50,024,424 | +28.8 % |
| 2024Q1 | 231 | +1 | 38,830,631 | -11.4 % |
| 2023Q4 | 230 | 43,813,060 |
Institutional managers
259 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 13,034,434 | 250.3M $ | as of Mar 31, 2026 |
| BAILLIE GIFFORD & CO | 12,066,479 | 231.7M $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 8,519,192 | 163.6K $ | as of Mar 31, 2026 |
| Temasek Holdings (Private) Ltd | 7,012,974 | 134.6M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 6,272,001 | 120.4M $ | as of Mar 31, 2026 |
| FMR LLC | 4,575,374 | 87.8M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 4,432,314 | 85.1M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 4,407,255 | 84.6M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 3,731,695 | 71.6M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,727,114 | 71.6M $ | as of Mar 31, 2026 |
| Holocene Advisors, LP | 3,195,429 | 61.4M $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 2,893,618 | 47.8M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 2,692,175 | 51.7M $ | as of Mar 31, 2026 |
| UBS Group AG | 2,571,344 | 49.4M $ | as of Mar 31, 2026 |
| Pictet Asset Management Holding SA | 2,558,865 | 48.4M $ | as of Mar 31, 2026 |
| Capital Research Global Investors | 2,514,588 | 48.3M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,464,146 | 47.3K $ | as of Mar 31, 2026 |
| Fisher Asset Management, LLC | 2,436,895 | 46.8M $ | as of Mar 31, 2026 |
| Crestline Management, L.P. | 2,210,732 | 42.4M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 1,941,123 | 37.3M $ | as of Mar 31, 2026 |
| Lynx1 Capital Management LP | 1,880,303 | 36.1M $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 1,871,455 | 35.9M $ | as of Mar 31, 2026 |
| Aberdeen Group plc | 1,854,446 | 35.6M $ | as of Mar 31, 2026 |
| Casdin Capital, LLC | 1,840,000 | 35.3M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 1,773,326 | 34M $ | as of Mar 31, 2026 |
Declared shareholders of Denali Therapeutics Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 5.40 % | 8,519,192 | as of Mar 31, 2026 · SCHEDULE 13G |
| FMR LLC and 1 other | 4.20 % | 6,672,999 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Denali Therapeutics Inc". https://titelia.com/en/stocks/denali-therapeutics-inc-US24823R1059